151 related articles for article (PubMed ID: 30828075)
1. A Network Pharmacology Approach Used to Estimate the Active Ingredients of Moutan Cortex Charcoal and the Potential Targets in Hemorrhagic Diseases.
Li S; Xue X; Yang X; Zhou S; Wang S; Meng J
Biol Pharm Bull; 2019; 42(3):432-441. PubMed ID: 30828075
[TBL] [Abstract][Full Text] [Related]
2.
Cheng P; Xue X; Su J; Lu M; Wang S; Meng J
J Pharm Biomed Anal; 2019 May; 169():151-158. PubMed ID: 30861407
[TBL] [Abstract][Full Text] [Related]
3. [The quality control of carbonized cortex moutan].
Zhou LY; Liang SW; Wang SM; Chen AL; Fu LJ
Zhong Yao Cai; 2007 Dec; 30(12):1502-5. PubMed ID: 18422180
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effects of extracts from Moutan Cortex on formation of advanced glycation end-products (AGEs) in vitro and specificity screening of its potential active components].
Chen J; Zhang L; Zhang MH; Zhao D; Yuan JR; Feng L; Jia XB
Zhongguo Zhong Yao Za Zhi; 2016 Mar; 41(5):891-897. PubMed ID: 28875645
[TBL] [Abstract][Full Text] [Related]
5. [Multicomponent Content Difference Among Different Processing Degrees of Moutan Cortex Charcoal].
Huang QY; Zhou SJ; Chen QF; Meng J; Wang SM
Zhong Yao Cai; 2016 May; 39(5):1024-7. PubMed ID: 30132639
[TBL] [Abstract][Full Text] [Related]
6. [Studies on content determination and fingerprint of active constituents in different parts of cortex moutan].
Zhou G; Lv QH
Zhongguo Zhong Yao Za Zhi; 2008 Sep; 33(18):2070-3. PubMed ID: 19160786
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of chemical compositions in Moutan Cortex, Paeoniae Rubra Radix and Paeoniae Alba Radix based on "component structure" theory].
Zhang L; Zhao BJ; Yuan JR; Wang CF; Feng L; Jia XB
Zhongguo Zhong Yao Za Zhi; 2016 May; 41(10):1835-1842. PubMed ID: 28895329
[TBL] [Abstract][Full Text] [Related]
8. [Study on the influence of the contents of paeonol in the cutting process of fresh Cortex Moutan].
Long QJ; Wang XG; Zhou Z; Zhao B
Zhong Yao Cai; 2012 Jun; 35(6):883-6. PubMed ID: 23236819
[TBL] [Abstract][Full Text] [Related]
9. Rapid characterization of chemical markers for discrimination of Moutan Cortex and its processed products by direct injection-based mass spectrometry profiling and metabolomic method.
Li CR; Li MN; Yang H; Li P; Gao W
Phytomedicine; 2018 Jun; 45():76-83. PubMed ID: 29685367
[TBL] [Abstract][Full Text] [Related]
10. Revealing metabolomic variations in Cortex Moutan from different root parts using HPLC-MS method.
Xiao C; Wu M; Chen Y; Zhang Y; Zhao X; Zheng X
Phytochem Anal; 2015; 26(1):86-93. PubMed ID: 25230378
[TBL] [Abstract][Full Text] [Related]
11. [Dynamic analysis of major active ingredients of Cortex Moutan cultivated in Dianjiang county of Chongqing].
Fan JA; Zhang Y; Xia YP; Qiu ZY; Yu C; Wang JS; Wang BH
Zhongguo Zhong Yao Za Zhi; 2007 Aug; 32(15):1501-4. PubMed ID: 17972572
[TBL] [Abstract][Full Text] [Related]
12. Capture of anti-coagulant active ingredients from Moutan Cortex by platelet immobilized chromatography and evaluation of anticoagulant activity in rats.
Qiu H; Zhang L; Zhu M; Zhang M; Chen J; Feng L; Jia X; Jacob JA
Biomed Pharmacother; 2017 Nov; 95():235-244. PubMed ID: 28843912
[TBL] [Abstract][Full Text] [Related]
13. Osteoblast Biospecific Extraction Conjugated with HPLC Analysis for Screening Bone Regeneration Active Components from Moutan Cortex.
Yao F; Chen W; Gu W; Xu H; Hou W; Liang G; Zhang Zhu R; Jiang G; Zhang L
Comb Chem High Throughput Screen; 2024; 27(6):834-844. PubMed ID: 37287301
[TBL] [Abstract][Full Text] [Related]
14. [Dynamic change of flavonoids' content in various extent of cortex moutan carbonisatum].
Ding A; Zhang L; Zhao X; Li X
Zhongguo Zhong Yao Za Zhi; 2009 Apr; 34(8):965-8. PubMed ID: 19639776
[TBL] [Abstract][Full Text] [Related]
15. [Quality evaluation of Moutan Cortex Formula Granules].
DU XG; Jiang HJ; Zhang H; Yan JZ
Zhongguo Zhong Yao Za Zhi; 2019 May; 44(10):2065-2071. PubMed ID: 31355562
[TBL] [Abstract][Full Text] [Related]
16. [Discussion on quality control of preparations with cortex moutan in volume I pharmacopoeia of People's Republic of China (2005 edition)].
Tian YQ; Ding P; Yan XH; Hu WJ
Zhongguo Zhong Yao Za Zhi; 2008 Feb; 33(3):339-41. PubMed ID: 18536477
[TBL] [Abstract][Full Text] [Related]
17. Gallic Acid Is the Major Active Component of Cortex Moutan in Inhibiting Immune Maturation of Human Monocyte-Derived Dendritic Cells.
Chan BC; Li LF; Hu SQ; Wat E; Wong EC; Zhang VX; Lau CB; Wong CK; Hon KL; Hui PC; Leung PC
Molecules; 2015 Sep; 20(9):16388-403. PubMed ID: 26378505
[TBL] [Abstract][Full Text] [Related]
18. Searching for calcium antagonists for hypertension disease therapy from Moutan Cortex, using bioactivity integrated UHPLC-QTOF-MS.
Lu Y; Deng Y; Liu W; Jiang M; Bai G
Phytochem Anal; 2019 Jul; 30(4):456-463. PubMed ID: 30859657
[TBL] [Abstract][Full Text] [Related]
19. Combining network pharmacology with chromatographic fingerprinting and multicomponent quantitative analysis for the quality evaluation of Moutan Cortex.
Wang R; Wang X; Xia M; Yang L; Cheng W; Song Q
Biomed Chromatogr; 2022 Oct; 36(10):e5434. PubMed ID: 35791465
[TBL] [Abstract][Full Text] [Related]
20. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
